Skip to main content

Published locations for FDA Panel Backs Sunitinib for Pancreatic Neuroendocrine Tumors

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA Panel Backs Sunitinib for Pancreatic Neuroendocrine Tumors

User login

  • Reset your password
  • /content/fda-panel-backs-sunitinib-pancreatic-neuroendocrine-tumors-0
  • /familypracticenews/article/33773/oncology/fda-panel-backs-sunitinib-pancreatic-neuroendocrine-tumors
  • /ehospitalistnews/article/33773/oncology/fda-panel-backs-sunitinib-pancreatic-neuroendocrine-tumors
  • /familymedicine/article/33773/oncology/fda-panel-backs-sunitinib-pancreatic-neuroendocrine-tumors